Protective responses against experimental Mycobacterium leprae infection in mice induced by recombinant Bacillus Calmette-Guerin over-producing three putative protective antigen candidates

被引:17
作者
Ohara, N
Matsuoka, M
Nomaguchi, H
Naito, M
Yamada, T
机构
[1] Nagasaki Univ, Sch Dent, Nagasaki 8528588, Japan
[2] Natl Inst Infect Dis, Leprosy Res Ctr, Tokyo 1890002, Japan
关键词
leprosy; BCG; vaccine; recombinant; Ag85;
D O I
10.1016/S0264-410X(00)00439-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The components of Ag85 (Ag85A, Ag85B, and Ag85C) are putative protective antigen candidates against mycobacterial infection. A recombinant Mycobacterium boris Bacillus Calmette-Guerin (rBCG) over-producing Ag85A, Ag85B, and MPB51 (rBCG/BA51) was constructed. rBCG/BA51 could secrete these antigens at levels more than five times higher than parental BCG. Immunization of C57BL/6 and BALB/c mice with this rBCG reduced the multiplication of Mycobacterium leprae in the foot pads of both strains of mice. The inhibition by rBCG/BA51 was more evident than that by parental BCG. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1906 / 1910
页数:5
相关论文
共 29 条
[1]   IDENTIFICATION OF IMMUNODOMINANT ANTIGENS DURING INFECTION WITH MYCOBACTERIUM-TUBERCULOSIS [J].
ANDERSEN, P ;
ASKGAARD, D ;
GOTTSCHAU, A ;
BENNEDSEN, J ;
NAGAI, S ;
HERON, I .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1992, 36 (06) :823-831
[2]  
Chambers MA, 1997, J IMMUNOL, V158, P1742
[3]   INFLUENCE OF MOUSE STRAIN AND VACCINE VIABILITY ON T-CELL RESPONSES INDUCED BY MYCOBACTERIUM-BOVIS BACILLUS-CALMETTE-GUERIN [J].
DAUGELAT, S ;
LADEL, CH ;
KAUFMANN, SHE .
INFECTION AND IMMUNITY, 1995, 63 (05) :2033-2040
[4]  
Fine PEM, 1996, LANCET, V348, P17, DOI 10.1016/S0140-6736(96)02166-6
[5]   BCG VACCINATION AGAINST TUBERCULOSIS AND LEPROSY [J].
FINE, PEM .
BRITISH MEDICAL BULLETIN, 1988, 44 (03) :691-703
[6]  
HOLT DF, 1998, J IMMUNOL, V161, P1045
[7]   PROTECTIVE IMMUNITY AGAINST TUBERCULOSIS INDUCED BY VACCINATION WITH MAJOR EXTRACELLULAR PROTEINS OF MYCOBACTERIUM-TUBERCULOSIS [J].
HORWITZ, MA ;
LEE, BWE ;
DILLON, BJ ;
HARTH, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1530-1534
[8]   Immunogenicity and protective efficacy of a tuberculosis DNA vaccine [J].
Huygen, K ;
Content, J ;
Denis, O ;
Montgomery, DL ;
Yawman, AM ;
Deck, RR ;
DeWitt, CM ;
Orme, IM ;
Baldwin, S ;
DSouza, C ;
Drowart, A ;
Lozes, E ;
Vandenbussche, P ;
VanVooren, JP ;
Liu, MA ;
Ulmer, JB .
NATURE MEDICINE, 1996, 2 (08) :893-898
[9]   MAPPING OF TH1 HELPER T-CELL EPITOPES ON MAJOR SECRETED MYCOBACTERIAL ANTIGEN 85A IN MICE INFECTED WITH LIVE MYCOBACTERIUM-BOVIS BCG [J].
HUYGEN, K ;
LOZES, E ;
GILLES, B ;
DROWART, A ;
PALFLIET, K ;
JURION, F ;
ROLAND, I ;
ART, M ;
DUFAUX, M ;
NYABENDA, J ;
DEBRUYN, J ;
VANVOOREN, JP ;
DELEYS, R .
INFECTION AND IMMUNITY, 1994, 62 (02) :363-370
[10]  
KAWAMURA I, 1992, J IMMUNOL, V148, P2887